Study Associates 90-120 Minutes of Weekly Strength Training with Extended Lifespan

A landmark 30-year study claims to have found the "sweet spot" for strength training and longevity. The evidence is real — but so are the caveats.

The Study That Started the Conversation

On June 2, 2026, researchers published a longitudinal analysis in the British Journal of Sports Medicine tracking 147,374 adults across three decades [1]. The study drew from three well-known cohorts: the Health Professionals Follow-up Study (1992–2022), the Nurses' Health Study (2002–2021), and the Nurses' Health Study II (2003–2021) [2]. The average age at enrollment was 54. Over the monitoring period, 35,798 participants died.

The headline finding: adults who performed 90 to 119 minutes of strength training per week had a 13% lower risk of death from any cause compared to those who did none [1]. The reductions were even steeper for specific causes — 19% for cardiovascular disease and 27% for neurological disease [2]. Cancer mortality dropped most sharply at lower volumes, with a 21% reduction at just 1–29 minutes per week [1].

Participants were surveyed every two years about their exercise habits. Strength training was defined as weight lifting, push-ups, squats, and lunges. Aerobic exercise — walking, running, swimming, cycling — was measured in metabolic equivalent tasks (METs), a standardized unit of energy expenditure [2].

Source: BJSM 2026 / Shailendra et al. 2022

Data as of Jun 2, 2026CSV

How Large Is the Benefit, Really?

The 13% figure is a relative risk reduction, which can be misleading without context. If the baseline annual mortality risk for a 54-year-old is approximately 1%, a 13% relative reduction would translate to an absolute risk reduction of roughly 0.13 percentage points per year — meaningful at the population level, but modest for any given individual [3].

For comparison, the same study found that aerobic exercise above 7.5 MET-hours per week was associated with a 26–43% lower risk of death [1]. Combined high-volume aerobic exercise (45+ MET-hours per week) with any strength training was linked to a 53–58% lower risk [2]. Strength training alone is beneficial, but it is not a substitute for aerobic exercise — and the largest benefits come from doing both.

Source: Shailendra et al. 2022 / BJSM 2026

Data as of Jun 2, 2026CSV

A 2022 meta-analysis by Shailendra et al. in the American Journal of Preventive Medicine, reviewing multiple studies, found similar numbers: a 15% reduction in all-cause mortality, 19% for cardiovascular disease, and 14% for cancer among people who did any resistance training versus none [4]. When combined with aerobic exercise, the reduction reached 40% [4]. A separate 2022 meta-analysis by Momma et al. in the BJSM found resistance training alone was associated with a 21% lower risk of all-cause mortality [5].

The Dose-Response Puzzle

One of the more striking aspects of the evidence is the disagreement on optimal dose. The 2026 study places the sweet spot at 90–120 minutes per week [1]. But the 2022 Momma meta-analysis — analyzing 16 prospective cohort studies encompassing over 263,000 participants and 42,133 deaths — found maximum risk reduction of 10–20% at just 30–60 minutes per week, with a J-shaped curve suggesting diminishing or reversed returns beyond that [5].

Shailendra et al. found maximum risk reduction of 27% at approximately 60 minutes per week, also with diminishing returns at higher volumes [4].

The 2026 study does show a plateau: no additional mortality benefit was observed beyond 120 minutes per week [1]. Whether this represents a true ceiling or the beginning of a reversal is unclear, because the study did not have sufficient statistical power at high training volumes to detect a U-shaped curve [2]. Prior research has raised concerns about excessive resistance training contributing to arterial stiffness, particularly in younger individuals, and elevated cardiac stress markers [6]. But these effects remain poorly characterized in large population studies.

What Biology Might Explain the Association

Skeletal muscle is metabolically active tissue, and its preservation with aging appears to have broad physiological consequences. Muscle mass peaks in the late twenties to early thirties and declines by approximately 3–8% per decade thereafter [7]. By age 80, many individuals have lost roughly 30% of their peak muscle mass, a condition called sarcopenia that contributes to frailty, falls, fractures, and loss of independence [7].

Resistance training counteracts sarcopenia directly. But the proposed mechanisms go beyond muscle preservation. Contracting muscles release molecules called myokines — most notably interleukin-6 (IL-6), the first protein officially classified as a myokine — that improve insulin sensitivity, reduce systemic inflammation, and promote fat oxidation [8]. Resistance training increases GLUT4 receptor activity, enhancing glucose uptake into muscle cells, which helps explain the observed reductions in type 2 diabetes risk [9].

A meta-analysis of resistance training in elderly adults found significant reductions in C-reactive protein (CRP) and tumor necrosis factor alpha (TNF-α), both markers of chronic inflammation linked to cardiovascular disease and cancer [10]. Resistance training also stimulates brain-derived neurotrophic factor (BDNF), which supports neurogenesis and may partially explain the 27% reduction in neurological disease mortality found in the 2026 study [11].

These mechanisms are biologically plausible, but the mechanistic evidence comes primarily from small controlled studies of biomarkers, not from direct measurement of mortality outcomes. The gap between "strength training changes these blood markers" and "strength training prevents death" remains bridged almost entirely by observational association.

Who Benefits — and Who Was Actually Studied

The three cohorts in the 2026 study were health professionals and nurses — a population that is overwhelmingly white, educated, and middle- to upper-income [1]. Seventy-four percent of participants already met the recommended 150 minutes per week of moderate aerobic exercise, and 46% engaged in some strength training [2]. This is a far more active population than the general public, where only about 30.6% of U.S. adults meet minimum muscle-strengthening guidelines [12].

The study did not publish detailed demographic breakdowns of mortality benefit by race, income, or disability status [1]. Higher-volume strength trainers in the cohort tended to be younger and leaner, with healthier overall lifestyle profiles [2]. This pattern is consistent across the exercise-longevity literature: the people most likely to exercise regularly are also the people least likely to die prematurely for a host of other reasons.

Source: CDC MMWR 2023

Data as of Feb 3, 2023CSV

CDC data from 2023 shows stark geographic and socioeconomic gradients in strength training adherence. Only 21.1% of nonmetropolitan adults met muscle-strengthening guidelines, compared to 35.2% in large central metropolitan areas [12]. Adherence is lowest among older adults, women, Hispanic women, current smokers, people with low educational attainment, and those with functional limitations or chronic conditions [13]. A longitudinal analysis of national survey data found that adherence rose from 19.8% in 1997 to 27.2% in 2018, but remained below 30% throughout [13].

The gap between who was studied and who needs the intervention most is substantial. The mortality benefits observed in health professionals may not translate equally to populations with different baseline health, access to facilities, and competing health risks.

The Case for Skepticism

The strongest objection to the exercise-longevity literature is healthy-user bias: people who exercise regularly also tend to eat better, sleep more, smoke less, drink less, manage stress more effectively, and have higher incomes that afford better healthcare [14]. This is not merely a theoretical concern. A 2011 review in the Journal of General Internal Medicine detailed how healthy-user bias has systematically inflated the apparent benefits of preventive interventions in observational studies [14].

The 2026 study adjusted for known confounders including age, BMI, smoking status, alcohol intake, diet quality, and medical history [1]. But residual confounding — from factors that are difficult to measure, like sleep quality, social connection, psychological resilience, and access to preventive healthcare — cannot be fully eliminated in any observational design [15].

There is also the problem of reverse causation: people who are already sick exercise less, so the association between exercise and lower mortality may partly reflect the fact that healthier people are more capable of exercising, rather than exercise making people healthier [15]. The 2026 study attempted to address this by excluding deaths in the first two years of follow-up, but this is a partial correction at best [2].

No randomized controlled trial has ever assigned tens of thousands of people to strength train for decades and measured mortality outcomes — nor is such a trial likely to be conducted, because of ethical and practical constraints. The evidence base for strength training and longevity is, and will likely remain, observational.

What the Research Landscape Looks Like

The volume of academic research on resistance training and mortality has surged. According to OpenAlex data, publications in this area grew from approximately 4,157 in 2011 to a peak of 29,094 in 2025 — a seven-fold increase over 14 years [16].

Source: OpenAlex

Data as of Jan 1, 2026CSV

This growth reflects broader scientific interest in exercise as a modifiable risk factor for chronic disease. But volume of publication is not the same as quality or consensus. The field is characterized by a large number of observational studies with overlapping cohorts, varying definitions of "strength training," and inconsistent dose-response findings.

The Public Health Gap

If 90–120 minutes of weekly strength training is genuinely optimal for longevity, the gap between recommendation and reality is wide. The World Health Organization recommends at least two sessions per week of muscle-strengthening activity [17]. Only 23.5% of U.S. adults meet the combined aerobic and muscle-strengthening guidelines [12].

Closing this gap would require more than public messaging. Gym memberships, personal training, and safe exercise environments are unevenly distributed by income and geography. Rural communities, where adherence is lowest, often lack the facilities and programming that urban residents take for granted [12].

Some jurisdictions have begun to act. The U.K.'s National Health Service includes strength training recommendations in its physical activity guidelines. Australia's government-funded exercise prescription programs through the National Heart Foundation incorporate resistance training. Several U.S. states have piloted community-based strength training programs for older adults through Area Agencies on Aging, though these remain small in scale [17].

The cost-effectiveness question remains unanswered. If the mortality reduction is real and applies broadly, even modest investments in accessible strength training programs could produce large returns in reduced healthcare spending and disability-adjusted life years. But the evidence base for such projections depends on the same observational data whose limitations have already been noted.

Life Expectancy in Context

The conversation about strength training and longevity takes place against a backdrop of significant international variation in life expectancy. Swiss residents live an average of 84.4 years; Americans, 78.9 [18]. The factors driving these differences — healthcare system design, diet, poverty, gun violence, drug overdoses — dwarf anything that exercise policy alone can address.

Source: World Bank Open Data

Data as of Dec 31, 2024CSV

Strength training is not a substitute for structural public health investments. But as one modifiable behavior among many, the evidence suggests it carries benefits that extend well beyond aesthetics or athletic performance.

The Bottom Line

The 2026 BJSM study adds to a growing body of evidence that regular resistance training is associated with lower mortality risk, with 90–120 minutes per week appearing to mark the upper threshold of benefit [1]. The effect is modest when viewed in absolute terms and strongest when combined with aerobic exercise [2]. The biological mechanisms are plausible and increasingly well-characterized, spanning metabolic, inflammatory, musculoskeletal, and neurological pathways [8][9][10].

But the evidence is entirely observational, relies on self-reported exercise data, and comes from a study population that is healthier, wealthier, and more active than the general public [1][14]. Healthy-user bias remains a serious and unresolved confound. Prior meta-analyses disagree on the optimal dose, with some finding peak benefit at just 30–60 minutes per week [5].

For individuals, the practical takeaway is straightforward: some strength training is better than none, and more is better up to a point. For policymakers, the harder question is whether the evidence is strong enough to justify the investment needed to make strength training accessible to the populations who currently don't do it — and who may need it most.